Project Grant HT9425261E168
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hershey, PA 17033, USA
Similar Awards
- Federal Project Grant Award Summary The University of Pennsylvania received a $1,159,317 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports the EDISYN-LFS (Early Detection in Syndromic Neoplasms for Patients with Li-Fraumeni Syndrome) research initiative, which focuses on advancing early detection methodologies and biomarker discovery for cancer...
- Federal Grant Award Summary The University of Pennsylvania received a $581,220 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award supports research titled "Accelerating Post-Traumatic Epilepsy Research Through Data Integration and Verifiable Analysis at Scale," which will be conducted in Philadelphia, Pennsylvania. This modification adds $74,588...
- The U.S. Defense Health Agency awarded a $831,658 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project investigating "GUT-BRAIN MECHANISMS OF IMPROVING HEALTH IN AN ANIMAL MODEL OF SCI FOLLOWING WEIGHT LOSS SURGERY". As a leading academic medical center, Penn State has a track record of delivering...
- Federal Project Grant Award Summary The University of Pennsylvania received a $812,487 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2028. The award supports research titled "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer," to be conducted at the university's Philadelphia campus. Under this three-year...
- The U.S. Defense Health Agency awarded a $384,063 Project Grant to The Pennsylvania State University (Penn State) under the Military Medical Research and Development program (CFDA 12.420). The grant provides funding from February 1, 2025 through January 31, 2027 for a project titled "Direct Genetic Modification of Plasmodium Sporozoites by mRNA/Lipid Nanoparticles". The project aims to conduct advanced biomedical research into innovative medical solutions to address critical health...
- Federal Project Grant Award Summary Onward Medical Inc. received a $325,142 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a clinical-grade spinal cord neuroprosthesis designed to alleviate locomotor deficits in individuals with Parkinson's disease. The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research and technology development relevant to military and public...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $676,117 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, with completion scheduled for August 31, 2029. The research project focuses on expanded GAA-GGA chimeric repeats in Friedreich Ataxia, a rare neurological genetic disorder. This award supports biomedical research aimed at advancing medical...
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,255,505 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The grant, which has a performance period of July 1, 2024 to June 30, 2027, is for the development of a unique small molecule for the treatment of triple-negative breast cancer. As a leading academic medical center, Penn State has...
- Federal Project Grant Award Summary Colorado State University's Sponsored Programs Division received a $320,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with completion targeted for August 14, 2027. The research project, titled "Overlooked No More: The Impact of the Menstrual Cycle on Neuromuscular Function in Women with Multiple Sclerosis," will be conducted at the...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $934,501 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on developing peptide-centric chimeric antigen receptor (CAR) T-cell therapies for neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors...